MedPath

THE EFFECT OF BEHAVIOURAL MODIFICATION THERAPY ON TOBACCO CESSATION

Completed
Conditions
ready to quit smoking or smokeless tobacco use
Registration Number
CTRI/2022/07/043815
Lead Sponsor
ARUMUGAM P M
Brief Summary

India occupies a very special place in the world’s tobacco map. As the second most populous country in the world, India’s share of the global burden of tobacco induced disease and death is substantial and as the second largest producer and consumer of tobacco in the world.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
50
Inclusion Criteria
  • •Participants who will give informed consent to participate in the study. • Patients aged between 18.
  • 80yrs. •Patients using tobacco for more than 6 months. •A patient using tobacco for more than 3 times per day. •No subjects should have undergone any behavioural counselling in the four-week period prior to the baseline examination.
Exclusion Criteria
  • •Participants who don’t give informed consent to participate in the study.
  • •Pregnant or lactating females.
  • •Patient undergoing nicotine replacement therapy.
  • •Those who are undergoing antibiotic or anti-inflammatory therapy or on medication for any underlying systemic disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reduction in the consumption a number of cigarettes smoked and smokeless tobaccobaseline, 10th day, 30th day, 3 months, 6 months.
Secondary Outcome Measures
NameTimeMethod
Assess the complete abstinence for any form of tobacco use for at least a monthafter six months

Trial Locations

Locations (1)

Rajarajeswari dental college and hospital

🇮🇳

Bangalore, KARNATAKA, India

Rajarajeswari dental college and hospital
🇮🇳Bangalore, KARNATAKA, India
ARUMUGAM P M
Principal investigator
9942828607
aarumugampm27@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.